IGF-1R
Os inibidores de IGF-1R são compostos que especificamente alvo e inibem o Receptor do Fator de Crescimento Semelhante à Insulina 1 (IGF-1R), uma tirosina quinase receptora envolvida no crescimento celular, desenvolvimento e sobrevivência. A sinalização de IGF-1R desempenha um papel significativo na progressão do câncer, tornando esses inibidores valiosos na pesquisa oncológica. Na CymitQuimica, oferecemos inibidores de IGF-1R para apoiar sua pesquisa em biologia do câncer, endocrinologia e desenvolvimento de terapias direcionadas.
Foram encontrados 119 produtos para "IGF-1R".
Filtrar por
Percentagem de pureza
0
100
|
0
|
50
|
90
|
95
|
100
- Preços em ordem crescente
- Preços em ordem decrescente
- Menor grau de pureza
- Maior grau de pureza
- Estimativa de entrega mais rápida
GIP (1-30) amide,human
CAS:GIP (1-30) amide (Human) is a glucose-dependent insulinotropic polypeptide that stimulates insulin secretion, reducing postprandial glycemic issues.Fórmula:C162H240N40O47SPureza:98%Cor e Forma:SolidPeso molecular:3531.94Insulin α-chain (1-13)
CAS:Insulin alpha-chain peptide, amino acids 1-13, T cell-recognized, posttranslationally modified.Fórmula:C66H118N20O22S3Pureza:98%Cor e Forma:SolidPeso molecular:1639.96(Pro3) GIP, human
CAS:(Pro3) GIP, human: stable hGIPR full agonist, high affinity (Ki/Kd=0.90nM), for obesity-related diabetes research.Fórmula:C226H338N60O64SCor e Forma:SolidPeso molecular:4951.53Gastric Inhibitory Peptide (1-42) (porcine) TFA
Gastric Inhibitory Peptide (1-42) (porcine) TFA is a glucose-dependent insulinotropic polypeptide released by intestinal K-cells.Fórmula:C225H342N60O66S·XCF3COOHCor e Forma:White SolidPeso molecular:4975.55IGF-I (24-41)
CAS:IGF-I (24-41) is a fragment of IGF-I, affecting GH activities with anabolic, antioxidant, anti-inflammatory, and cytoprotective properties.Fórmula:C88H133N27O28Pureza:98%Cor e Forma:SolidPeso molecular:2017.16Proinsulin C-Peptide (55-89), human
CAS:Proinsulin, insulin's precursor, has A and B chains linked by a 31 amino acid C-peptide. Enzymes cleave it, yielding insulin and C-peptide.Fórmula:C153H259N49O52Pureza:98%Cor e Forma:SolidPeso molecular:3616.9907cis-NVP-ADW742
CAS:NVP-ADW742 is an IGF-1R inhibitor with IC50 of 0.17 μM, >16-fold more potent against IGF-1R than InsR; little activity to HER2, PDGFR, VEGFR-2, Bcr-Abl and c-Kit.Fórmula:C28H31N5OCor e Forma:SolidPeso molecular:453.59Acetyl Gastric Inhibitory Peptide (human)
CAS:Acetyl Gastric Inhibitory Peptide: improved insulinotropic, antihyperglycemic, for diabetes/obesity research.Fórmula:C228H340N60O67SCor e Forma:SolidPeso molecular:5025.6GIP, human
CAS:Insulinotropic hormone from K-cells, binds GIP receptors, boosts insulin, affects lipids, and has antiapoptotic properties.Fórmula:C226H338N60O66SPureza:98%Cor e Forma:SolidPeso molecular:4983.6Insulin peglispro
CAS:Insulin peglispro (BIL) is a basal insulin with a stable, extended activity and may offer improved blood sugar control.Fórmula:C370H566N104O110S4Cor e Forma:SolidPeso molecular:8359.32IGF-I (30-41)
CAS:IGF-I (30-41) is amino acids 30 to 41 fragment of Insulin-like Growth Factor I (IGF-I).Fórmula:C51H83N19O19Pureza:98%Cor e Forma:SolidPeso molecular:1266.34OI338
OI338 is an orally available, ultralong-acting insulin analogue.Fórmula:C260H403N65O84S6Cor e Forma:SolidPeso molecular:5971.76TAK-778
CAS:TAK-778, a derivative of ipriflavone, demonstrates the ability to stimulate bone growth in both in vitro and in vivo models.Fórmula:C24H28NO7PSPureza:97.72%Cor e Forma:SolidPeso molecular:505.52TLK19781
CAS:TLK19781 is an insulin receptor modulator.Fórmula:C33H24Cl2N4O13S4Pureza:98%Cor e Forma:SolidPeso molecular:883.73[Pro3]-GIP (Mouse)
GIP receptor blocker, 2.6μM IC50, hinders insulin release, regulates glucose in ob/ob mice, and enhances glucose tolerance.Fórmula:C225H342N62O64SPureza:98%Cor e Forma:SolidPeso molecular:4971.62WAY-270250
CAS:WAY-270250 is an IGF-1R/SRC inhibitor.Fórmula:C18H16N2O2Pureza:99.97%Cor e Forma:Green SolidPeso molecular:292.33LAGIPRA peptide
LAGIPRA peptide is a long-acting agonist of GIP1R. It improves insulin sensitivity by enhancing glucose handling and reduces circulating branched-chain amino acids (BCAA) and keto acids. LAGIPRA peptide holds potential for research in type 2 diabetes.[pTyr1146][pTyr1150][pTyr1151]Insulin Receptor (1142-1153)
CAS:Insulin Receptor (1142-1153) binds insulin, is a substrate for its kinase, and has research/medical potential.Fórmula:C72H110N19O33P3Pureza:98%Cor e Forma:SolidPeso molecular:1862.67[D-Ala2]-GIP (human)
CAS:[D-Ala2]-GIP (human), GIP agonist (EC₅₀=630 pM), improves glucose/cognition, anti-neurotoxicity, for diabetes and Parkinson's.Fórmula:C226H338N60O66SPureza:98%Cor e Forma:SolidPeso molecular:4983.58IGF-1R inhibitor-2
CAS:IGF-1R inhibitor-2 blocks the insulin-like growth factor-1 receptor, potentially reversing tumor cell transformation and increasing apoptosis susceptibility.Fórmula:C24H24FN7O2Cor e Forma:SolidPeso molecular:461.501
![[Pro3]-GIP (Mouse)](https://static.cymitquimica.com/products/TM/thumb-webp/TP2020.webp)
![[pTyr1146][pTyr1150][pTyr1151]Insulin Receptor (1142-1153)](https://static.cymitquimica.com/products/TM/thumb-webp/TP1259.webp)
![[D-Ala2]-GIP (human)](https://static.cymitquimica.com/products/TM/thumb-webp/TP2019.webp)
